Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0% Income from operations increased 15%; non-GAAP ...
StockStory.org on MSN
ResMed’s (NYSE:RMD) Q1 CY2026 sales beat estimates
Medical device company ResMed (NYSE:RMD) reported in Q1 CY2026, with sales up 10.8% year on year to $1.43 billion. Its ...
ResMed delivered stronger-than-expected Q1 results with revenue up 10.8% and EPS above estimates, driven by demand for masks, devices, and supply chain gains. The company announced CFO Brett ...
Earlier this week, ResMed (NYSE:RMD) reported that it will release its quarterly earnings on Thursday afternoon, with Wall Street expecting around 10% year-on-year revenue growth and earnings of about ...
ResMed stock's high valuation from 4 years ago is finally being reflected in the current stock price. The historical earnings pattern of ResMed has been stable and consistent, making it a rare ...
RMD gears up for fiscal Q3 earnings with steady estimates, rising demand in sleep devices and AI-driven digital health tools ...
ResMed (NYSE:RMD) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
Medical device company ResMed (NYSE:RMD) will be announcing earnings results this Thursday afternoon. Here’s what to look for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results